Global Human Vaccination Market Research Report 2024

Report ID: 1871016 | Published Date: Jan 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Human Vaccination Market Overview
    1.1 Product Overview and Scope of Human Vaccination
    1.2 Human Vaccination Segment by Type
        1.2.1 Global Human Vaccination Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Inactivated Vaccine
        1.2.3 Live-attenuated Vaccine
        1.2.4 mRNA Vaccine
        1.2.5 Conjugate Vaccine
        1.2.6 Other
    1.3 Human Vaccination Segment by Application
        1.3.1 Global Human Vaccination Sales Comparison by Application: (2022-2028)
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Global Human Vaccination Market Size Estimates and Forecasts
        1.4.1 Global Human Vaccination Revenue 2017-2028
        1.4.2 Global Human Vaccination Sales 2017-2028
        1.4.3 Human Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028
2 Human Vaccination Market Competition by Manufacturers
    2.1 Global Human Vaccination Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Human Vaccination Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Human Vaccination Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Human Vaccination Manufacturing Sites, Area Served, Product Type
    2.5 Human Vaccination Market Competitive Situation and Trends
        2.5.1 Human Vaccination Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Human Vaccination Players Market Share by Revenue
        2.5.3 Global Human Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Vaccination Retrospective Market Scenario by Region
    3.1 Global Human Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Human Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Human Vaccination Market Facts & Figures by Country
        3.3.1 North America Human Vaccination Sales by Country
        3.3.2 North America Human Vaccination Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Human Vaccination Market Facts & Figures by Country
        3.4.1 Europe Human Vaccination Sales by Country
        3.4.2 Europe Human Vaccination Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Human Vaccination Market Facts & Figures by Region
        3.5.1 Asia Pacific Human Vaccination Sales by Region
        3.5.2 Asia Pacific Human Vaccination Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Human Vaccination Market Facts & Figures by Country
        3.6.1 Latin America Human Vaccination Sales by Country
        3.6.2 Latin America Human Vaccination Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Human Vaccination Market Facts & Figures by Country
        3.7.1 Middle East and Africa Human Vaccination Sales by Country
        3.7.2 Middle East and Africa Human Vaccination Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Human Vaccination Historic Market Analysis by Type
    4.1 Global Human Vaccination Sales Market Share by Type (2017-2022)
    4.2 Global Human Vaccination Revenue Market Share by Type (2017-2022)
    4.3 Global Human Vaccination Price by Type (2017-2022)
5 Global Human Vaccination Historic Market Analysis by Application
    5.1 Global Human Vaccination Sales Market Share by Application (2017-2022)
    5.2 Global Human Vaccination Revenue Market Share by Application (2017-2022)
    5.3 Global Human Vaccination Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 GSK
        6.1.1 GSK Corporation Information
        6.1.2 GSK Description and Business Overview
        6.1.3 GSK Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 GSK Human Vaccination Product Portfolio
        6.1.5 GSK Recent Developments/Updates
    6.2 Merck
        6.2.1 Merck Corporation Information
        6.2.2 Merck Description and Business Overview
        6.2.3 Merck Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Merck Human Vaccination Product Portfolio
        6.2.5 Merck Recent Developments/Updates
    6.3 Sanofi
        6.3.1 Sanofi Corporation Information
        6.3.2 Sanofi Description and Business Overview
        6.3.3 Sanofi Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Sanofi Human Vaccination Product Portfolio
        6.3.5 Sanofi Recent Developments/Updates
    6.4 Sinovac
        6.4.1 Sinovac Corporation Information
        6.4.2 Sinovac Description and Business Overview
        6.4.3 Sinovac Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sinovac Human Vaccination Product Portfolio
        6.4.5 Sinovac Recent Developments/Updates
    6.5 Zhejiang Pukang
        6.5.1 Zhejiang Pukang Corporation Information
        6.5.2 Zhejiang Pukang Description and Business Overview
        6.5.3 Zhejiang Pukang Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Zhejiang Pukang Human Vaccination Product Portfolio
        6.5.5 Zhejiang Pukang Recent Developments/Updates
    6.6 Changchun Institute of Biological
        6.6.1 Changchun Institute of Biological Corporation Information
        6.6.2 Changchun Institute of Biological Description and Business Overview
        6.6.3 Changchun Institute of Biological Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Changchun Institute of Biological Human Vaccination Product Portfolio
        6.6.5 Changchun Institute of Biological Recent Developments/Updates
    6.7 KM Biologics
        6.6.1 KM Biologics Corporation Information
        6.6.2 KM Biologics Description and Business Overview
        6.6.3 KM Biologics Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 KM Biologics Human Vaccination Product Portfolio
        6.7.5 KM Biologics Recent Developments/Updates
    6.8 IMBCAMS
        6.8.1 IMBCAMS Corporation Information
        6.8.2 IMBCAMS Description and Business Overview
        6.8.3 IMBCAMS Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 IMBCAMS Human Vaccination Product Portfolio
        6.8.5 IMBCAMS Recent Developments/Updates
    6.9 Convac
        6.9.1 Convac Corporation Information
        6.9.2 Convac Description and Business Overview
        6.9.3 Convac Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Convac Human Vaccination Product Portfolio
        6.9.5 Convac Recent Developments/Updates
    6.10 NCPC
        6.10.1 NCPC Corporation Information
        6.10.2 NCPC Description and Business Overview
        6.10.3 NCPC Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 NCPC Human Vaccination Product Portfolio
        6.10.5 NCPC Recent Developments/Updates
    6.11 Bio Kangtai
        6.11.1 Bio Kangtai Corporation Information
        6.11.2 Bio Kangtai Human Vaccination Description and Business Overview
        6.11.3 Bio Kangtai Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Bio Kangtai Human Vaccination Product Portfolio
        6.11.5 Bio Kangtai Recent Developments/Updates
    6.12 Dynavax
        6.12.1 Dynavax Corporation Information
        6.12.2 Dynavax Human Vaccination Description and Business Overview
        6.12.3 Dynavax Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Dynavax Human Vaccination Product Portfolio
        6.12.5 Dynavax Recent Developments/Updates
    6.13 Hissen
        6.13.1 Hissen Corporation Information
        6.13.2 Hissen Human Vaccination Description and Business Overview
        6.13.3 Hissen Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Hissen Human Vaccination Product Portfolio
        6.13.5 Hissen Recent Developments/Updates
    6.14 KM Biologics
        6.14.1 KM Biologics Corporation Information
        6.14.2 KM Biologics Human Vaccination Description and Business Overview
        6.14.3 KM Biologics Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 KM Biologics Human Vaccination Product Portfolio
        6.14.5 KM Biologics Recent Developments/Updates
    6.15 LG Life Sciences
        6.15.1 LG Life Sciences Corporation Information
        6.15.2 LG Life Sciences Human Vaccination Description and Business Overview
        6.15.3 LG Life Sciences Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 LG Life Sciences Human Vaccination Product Portfolio
        6.15.5 LG Life Sciences Recent Developments/Updates
    6.16 Serum Institute
        6.16.1 Serum Institute Corporation Information
        6.16.2 Serum Institute Human Vaccination Description and Business Overview
        6.16.3 Serum Institute Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Serum Institute Human Vaccination Product Portfolio
        6.16.5 Serum Institute Recent Developments/Updates
    6.17 Pfizer
        6.17.1 Pfizer Corporation Information
        6.17.2 Pfizer Human Vaccination Description and Business Overview
        6.17.3 Pfizer Human Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Pfizer Human Vaccination Product Portfolio
        6.17.5 Pfizer Recent Developments/Updates
7 Human Vaccination Manufacturing Cost Analysis
    7.1 Human Vaccination Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Human Vaccination
    7.4 Human Vaccination Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Human Vaccination Distributors List
    8.3 Human Vaccination Customers
9 Human Vaccination Market Dynamics
    9.1 Human Vaccination Industry Trends
    9.2 Human Vaccination Market Drivers
    9.3 Human Vaccination Market Challenges
    9.4 Human Vaccination Market Restraints
10 Global Market Forecast
    10.1 Human Vaccination Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Human Vaccination by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Human Vaccination by Type (2023-2028)
    10.2 Human Vaccination Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Human Vaccination by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Human Vaccination by Application (2023-2028)
    10.3 Human Vaccination Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Human Vaccination by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Human Vaccination by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Human Vaccination Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
    Table 2. Global Human Vaccination Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
    Table 3. Global Human Vaccination Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Human Vaccination Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Human Vaccination Sales (Units) of Key Manufacturers (2017-2022)
    Table 6. Global Human Vaccination Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Human Vaccination Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Human Vaccination Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Human Vaccination Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Human Vaccination Manufacturing Sites and Area Served
    Table 11. Manufacturers Human Vaccination Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Human Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccination as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Human Vaccination Sales by Region (2017-2022) & (Units)
    Table 16. Global Human Vaccination Sales Market Share by Region (2017-2022)
    Table 17. Global Human Vaccination Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Human Vaccination Revenue Market Share by Region (2017-2022)
    Table 19. North America Human Vaccination Sales by Country (2017-2022) & (Units)
    Table 20. North America Human Vaccination Sales Market Share by Country (2017-2022)
    Table 21. North America Human Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Human Vaccination Revenue Market Share by Country (2017-2022)
    Table 23. Europe Human Vaccination Sales by Country (2017-2022) & (Units)
    Table 24. Europe Human Vaccination Sales Market Share by Country (2017-2022)
    Table 25. Europe Human Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Human Vaccination Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Human Vaccination Sales by Region (2017-2022) & (Units)
    Table 28. Asia Pacific Human Vaccination Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Human Vaccination Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Human Vaccination Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Human Vaccination Sales by Country (2017-2022) & (Units)
    Table 32. Latin America Human Vaccination Sales Market Share by Country (2017-2022)
    Table 33. Latin America Human Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Human Vaccination Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Human Vaccination Sales by Country (2017-2022) & (Units)
    Table 36. Middle East and Africa Human Vaccination Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Human Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Human Vaccination Revenue Market Share by Country (2017-2022)
    Table 39. Global Human Vaccination Sales by Type (2017-2022) & (Units)
    Table 40. Global Human Vaccination Sales Market Share by Type (2017-2022)
    Table 41. Global Human Vaccination Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Human Vaccination Revenue Share by Type (2017-2022)
    Table 43. Global Human Vaccination Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Human Vaccination Sales (Units) by Application (2017-2022)
    Table 45. Global Human Vaccination Sales Market Share by Application (2017-2022)
    Table 46. Global Human Vaccination Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Human Vaccination Revenue Share by Application (2017-2022)
    Table 48. Global Human Vaccination Price by Application (2017-2022) & (US$/Unit)
    Table 49. GSK Corporation Information
    Table 50. GSK Description and Business Overview
    Table 51. GSK Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. GSK Human Vaccination Product
    Table 53. GSK Recent Developments/Updates
    Table 54. Merck Corporation Information
    Table 55. Merck Description and Business Overview
    Table 56. Merck Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Merck Human Vaccination Product
    Table 58. Merck Recent Developments/Updates
    Table 59. Sanofi Corporation Information
    Table 60. Sanofi Description and Business Overview
    Table 61. Sanofi Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Sanofi Human Vaccination Product
    Table 63. Sanofi Recent Developments/Updates
    Table 64. Sinovac Corporation Information
    Table 65. Sinovac Description and Business Overview
    Table 66. Sinovac Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Sinovac Human Vaccination Product
    Table 68. Sinovac Recent Developments/Updates
    Table 69. Zhejiang Pukang Corporation Information
    Table 70. Zhejiang Pukang Description and Business Overview
    Table 71. Zhejiang Pukang Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Zhejiang Pukang Human Vaccination Product
    Table 73. Zhejiang Pukang Recent Developments/Updates
    Table 74. Changchun Institute of Biological Corporation Information
    Table 75. Changchun Institute of Biological Description and Business Overview
    Table 76. Changchun Institute of Biological Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Changchun Institute of Biological Human Vaccination Product
    Table 78. Changchun Institute of Biological Recent Developments/Updates
    Table 79. KM Biologics Corporation Information
    Table 80. KM Biologics Description and Business Overview
    Table 81. KM Biologics Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. KM Biologics Human Vaccination Product
    Table 83. KM Biologics Recent Developments/Updates
    Table 84. IMBCAMS Corporation Information
    Table 85. IMBCAMS Description and Business Overview
    Table 86. IMBCAMS Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. IMBCAMS Human Vaccination Product
    Table 88. IMBCAMS Recent Developments/Updates
    Table 89. Convac Corporation Information
    Table 90. Convac Description and Business Overview
    Table 91. Convac Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Convac Human Vaccination Product
    Table 93. Convac Recent Developments/Updates
    Table 94. NCPC Corporation Information
    Table 95. NCPC Description and Business Overview
    Table 96. NCPC Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. NCPC Human Vaccination Product
    Table 98. NCPC Recent Developments/Updates
    Table 99. Bio Kangtai Corporation Information
    Table 100. Bio Kangtai Description and Business Overview
    Table 101. Bio Kangtai Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Bio Kangtai Human Vaccination Product
    Table 103. Bio Kangtai Recent Developments/Updates
    Table 104. Dynavax Corporation Information
    Table 105. Dynavax Description and Business Overview
    Table 106. Dynavax Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Dynavax Human Vaccination Product
    Table 108. Dynavax Recent Developments/Updates
    Table 109. Hissen Corporation Information
    Table 110. Hissen Description and Business Overview
    Table 111. Hissen Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Hissen Human Vaccination Product
    Table 113. Hissen Recent Developments/Updates
    Table 114. KM Biologics Corporation Information
    Table 115. KM Biologics Description and Business Overview
    Table 116. KM Biologics Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. KM Biologics Human Vaccination Product
    Table 118. KM Biologics Recent Developments/Updates
    Table 119. LG Life Sciences Corporation Information
    Table 120. LG Life Sciences Description and Business Overview
    Table 121. LG Life Sciences Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. LG Life Sciences Human Vaccination Product
    Table 123. LG Life Sciences Recent Developments/Updates
    Table 124. Serum Institute Corporation Information
    Table 125. Serum Institute Description and Business Overview
    Table 126. Serum Institute Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Serum Institute Human Vaccination Product
    Table 128. Serum Institute Recent Developments/Updates
    Table 129. Pfizer Corporation Information
    Table 130. Pfizer Description and Business Overview
    Table 131. Pfizer Human Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Pfizer Human Vaccination Product
    Table 133. Pfizer Recent Developments/Updates
    Table 134. Production Base and Market Concentration Rate of Raw Material
    Table 135. Key Suppliers of Raw Materials
    Table 136. Human Vaccination Distributors List
    Table 137. Human Vaccination Customers List
    Table 138. Human Vaccination Market Trends
    Table 139. Human Vaccination Market Drivers
    Table 140. Human Vaccination Market Challenges
    Table 141. Human Vaccination Market Restraints
    Table 142. Global Human Vaccination Sales Forecast by Type (2023-2028) & (Units)
    Table 143. Global Human Vaccination Sales Market Share Forecast by Type (2023-2028)
    Table 144. Global Human Vaccination Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 145. Global Human Vaccination Revenue Market Share Forecast by Type (2023-2028)
    Table 146. Global Human Vaccination Sales Forecast by Application (2023-2028) & (Units)
    Table 147. Global Human Vaccination Sales Market Share Forecast by Application (2023-2028)
    Table 148. Global Human Vaccination Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 149. Global Human Vaccination Revenue Market Share Forecast by Application (2023-2028)
    Table 150. Global Human Vaccination Sales Forecast by Region (2023-2028) & (Units)
    Table 151. Global Human Vaccination Sales Market Share Forecast by Region (2023-2028)
    Table 152. Global Human Vaccination Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 153. Global Human Vaccination Revenue Market Share Forecast by Region (2023-2028)
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Vaccination
    Figure 2. Global Human Vaccination Market Share by Type in 2021 & 2028
    Figure 3. Inactivated Vaccine Product Picture
    Figure 4. Live-attenuated Vaccine Product Picture
    Figure 5. mRNA Vaccine Product Picture
    Figure 6. Conjugate Vaccine Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Human Vaccination Market Share by Application in 2021 & 2028
    Figure 9. Government Institution
    Figure 10. Private Sector
    Figure 11. Other
    Figure 12. Global Human Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Human Vaccination Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Human Vaccination Sales (2017-2028) & (Units)
    Figure 15. Human Vaccination Sales Share by Manufacturers in 2021
    Figure 16. Global Human Vaccination Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Human Vaccination Players: Market Share by Revenue in 2021
    Figure 18. Human Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Human Vaccination Sales Market Share by Region (2017-2022)
    Figure 20. Global Human Vaccination Sales Market Share by Region in 2021
    Figure 21. Global Human Vaccination Revenue Market Share by Region (2017-2022)
    Figure 22. Global Human Vaccination Revenue Market Share by Region in 2021
    Figure 23. United States Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. China Taiwan Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Human Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Human Vaccination by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Human Vaccination
    Figure 47. Manufacturing Process Analysis of Human Vaccination
    Figure 48. Human Vaccination Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
Frequently Asked Questions
Human Vaccination report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Vaccination report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Vaccination report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports